Rare Diseases 2026
Coalesce Research Group is pleased to announce the 4th International Conference on Rare Diseases and Orphan Drugs, set to take place on October 22-23, 2026, in Hotel Best Front Maritim, Barcelona, Spain. This two-day conference is designed to serve as a global platform for experts, stakeholders, and advocates to discuss advancements, challenges, and opportunities in the rare diseases and orphan drugs sector.
The primary objective of Rare Diseases 2026 is to raise awareness, foster collaboration, and accelerate progress in addressing the complex needs of individuals affected by rare diseases. The conference will facilitate dialogue and knowledge exchange among diverse stakeholders involved in rare disease research, drug development, patient care, advocacy, and policy-making.
Rare Diseases 2026
Coalesce Research Group is pleased to announce the 4th International Conference on Rare Diseases and Orphan Drugs, set to take place on October 22-23, 2026, in Hotel Best Front Maritim, Barcelona, Spain. This two-day conference is designed to serve as a global platform for experts, stakeholders, and advocates to discuss advancements, challenges, and opportunities in the rare diseases and orphan drugs sector.
The primary objective of Rare Diseases 2026 is to raise awareness, foster collaboration, and accelerate progress in addressing the complex needs of individuals affected by rare diseases. The conference will facilitate dialogue and knowledge exchange among diverse stakeholders involved in rare disease research, drug development, patient care, advocacy, and policy-making.
Rare Diseases 2026
Coalesce Research Group is pleased to announce the 4th International Conference on Rare Diseases and Orphan Drugs, set to take place on October 22-23, 2026, in Hotel Best Front Maritim, Barcelona, Spain. This two-day conference is designed to serve as a global platform for experts, stakeholders, and advocates to discuss advancements, challenges, and opportunities in the rare diseases and orphan drugs sector.
The primary objective of Rare Diseases 2026 is to raise awareness, foster collaboration, and accelerate progress in addressing the complex needs of individuals affected by rare diseases. The conference will facilitate dialogue and knowledge exchange among diverse stakeholders involved in rare disease research, drug development, patient care, advocacy, and policy-making.